Incidence of SARS-CoV-2 infection among previously infected or vaccinated employees

[1]  Eleanor L. Ross,et al.  An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Nowacki,et al.  Necessity of COVID-19 Vaccination in Previously Infected Individuals: A Retrospective Cohort Study , 2021, medRxiv.

[3]  C. Shyu,et al.  Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  R. Hoek,et al.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. , 2021, The New England journal of medicine.

[5]  O. Laeyendecker,et al.  CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants , 2021, Open forum infectious diseases.

[6]  O. Laeyendecker,et al.  CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants , 2021, medRxiv.

[7]  P. Kellam,et al.  T cell response to SARS-CoV-2 infection in humans: A systematic review , 2021, PLoS ONE.

[8]  M. Nussenzweig,et al.  Evolution of antibody immunity to SARS-CoV-2 , 2021, Nature.

[9]  M. Nussenzweig,et al.  Evolution of Antibody Immunity to SARS-CoV-2 , 2020, bioRxiv.

[10]  J. Klausner,et al.  Self-Collected Oral Fluid and Nasal Swab Specimens Demonstrate Comparable Sensitivity to Clinician-Collected Nasopharyngeal Swab Specimens for the Detection of SARS-CoV-2 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Doshi.  Covid-19: Do many people have pre-existing immunity? , 2020, BMJ.

[12]  Martin Linster,et al.  SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls , 2020, Nature.